Dorling A - Search Results

1

Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome.

Willicombe M, Roufosse C, Brookes P, Galliford JW, McLean AG, Dorling A, Warrens AN, Cook TH, Cairns TD, Taube D. Willicombe M, et al. Among authors: dorling a. Transplantation. 2011 Jul 27;92(2):176-82. doi: 10.1097/TP.0b013e318222c9c6. Transplantation. 2011. PMID: 21637139

2

Antiphospholipid syndrome and acute adrenal insufficiency.

Dorling A, Knowles GK. Dorling A, et al. J R Soc Med. 1991 Sep;84(9):560. doi: 10.1177/014107689108400920. J R Soc Med. 1991. PMID: 1941861 Free PMC article. No abstract available.

3

The prospects for xenotransplantation.

Warrens AN, Dorling A, Lechler RI. Warrens AN, et al. Among authors: dorling a. QJM. 1996 Dec;89(12):885-91. doi: 10.1093/qjmed/89.12.885. QJM. 1996. PMID: 9015482 Review. No abstract available.

4

Clinical xenotransplantation of solid organs.

Dorling A, Riesbeck K, Warrens A, Lechler R. Dorling A, et al. Lancet. 1997 Mar 22;349(9055):867-71. doi: 10.1016/S0140-6736(96)09404-4. Lancet. 1997. PMID: 9121275 Review.

5

Inhibition of tissue factor-dependent and -independent coagulation by cell surface expression of novel anticoagulant fusion proteins.

Chen D, Riesbeck K, Kemball-Cook G, McVey JH, Tuddenham EG, Lechler RI, Dorling A. Chen D, et al. Among authors: dorling a. Transplantation. 1999 Feb 15;67(3):467-74. doi: 10.1097/00007890-199902150-00021. Transplantation. 1999. PMID: 10030296

6

Graft-specific inhibition of complement activation after xenotransplantation; genetically modified pig organs versus systemic anticomplement strategies.

Dorling A. Dorling A. Transplantation. 2000 Mar 27;69(6):1033-4. doi: 10.1097/00007890-200003270-00002. Transplantation. 2000. PMID: 10762202 No abstract available.

7

The challenge of graft-specific immunosuppression in xenotransplantation.

Dorling A. Dorling A. Transplantation. 2000 May 15;69(9):1774-5. doi: 10.1097/00007890-200005150-00007. Transplantation. 2000. PMID: 10830209 No abstract available.

8

HLA-G inhibits the transendothelial cell migration of human NK cells: a strategy for inhibiting xenograft rejection.

Dorling A, Monk N, Lechler R. Dorling A, et al. Transplant Proc. 2000 Aug;32(5):938. doi: 10.1016/s0041-1345(00)01047-2. Transplant Proc. 2000. PMID: 10936283 No abstract available.

9

Immunosuppression of direct T-cell-mediated xenorecognition in vitro.

Rogers NJ, Mirenda V, Jackson I, Dorling A, Lechler RI. Rogers NJ, et al. Among authors: dorling a. Transplant Proc. 2001 Feb-Mar;33(1-2):697-8. doi: 10.1016/s0041-1345(00)02209-0. Transplant Proc. 2001. PMID: 11267024 No abstract available.

10

Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-alpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody.

Delikouras A, Hayes M, Malde P, Lechler RI, Dorling A. Delikouras A, et al. Among authors: dorling a. Transplantation. 2001 Mar 15;71(5):599-605. doi: 10.1097/00007890-200103150-00004. Transplantation. 2001. PMID: 11292287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters